Page last updated: 2024-12-07

dimyristoylmethylphosphatidic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Dimyristoylmethylphosphatidic acid (DMPA) is a synthetic phospholipid analog. It has been extensively studied for its ability to act as a potent activator of protein kinase C (PKC) signaling pathways, both in vitro and in vivo. DMPA is synthesized by chemical modification of diacylglycerol (DAG), a naturally occurring lipid that is a crucial second messenger in cellular signaling. It acts as a powerful agonist of PKC, mimicking the effects of DAG. This activation of PKC leads to a cascade of cellular responses, including cell proliferation, differentiation, and gene expression. DMPA has been utilized in research to investigate the role of PKC in various biological processes, such as inflammation, cancer, and neurotransmission. Due to its potent PKC-activating properties, DMPA has also been explored as a potential therapeutic agent for various diseases, including Alzheimer's disease and cancer. However, its use in clinical settings is still under investigation, and its safety and efficacy require further evaluation.'

dimyristoylmethylphosphatidic acid: RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122206
MeSH IDM0093554

Synonyms (15)

Synonym
dmmpa
dimyristoylmethylphosphatidic acid
[3-[hydroxy(methoxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] tetradecanoate
1,2-dtpm
dimyristoyl methylphosphatidic acid
1,2-dmpm
1,2-dimyristoylphosphatidylmethanol
1,2-ditetradecyl-sn-glycero-3-phosphomethanol
54672-40-1
1,2-dimyristoylphosphatidylmethanol ester
tetradecanoic acid, 1-(((hydroxymethoxyphosphinyl)oxy)methyl)-1,2-ethanediyl ester
dimyristoylphosphatidylmethanol
3-hydroxy-3,9-dioxo-2,4,8-trioxa-3lambda~5~-phosphadocosan-6-yl tetradecanoate
DTXSID60969967
pmeoh 14:0_14:0
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (26.67)18.7374
1990's21 (70.00)18.2507
2000's1 (3.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.29 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]